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1. Introduction 
The antibiotic doxorubicin (tig.la) is a highly 
active anticancer agent in current clinical use [ 11. It 
is believed that the inhibitory effect of this compound 
on both normal and tumour cell growth is due to its 
interference with RNA synthesis by binding directly 
to the double-stranded DNA template [2]. X-Ray 
fiber diffraction studies are believed to support a 
binding model in which intercalation between DNA 
base pairs, with consequent helix unwinding, plays an 
important role [3]. The crystallographic analysis of 
doxorubicin has not been determined. However, the 
crystal structures of daunomycin (fig.lb) as pyridine 
[4] and butanol [S] adducts, the N-bromoacetyl 
derivative of daunomycin [6] and 4hydroxy- 
daunomycin (carminomycin) [7-91 have been deter- 
mined by X-ray analysis. 
Neidle and Taylor have reported in this yournal 
[lo] an intramolecular conformational analysis of 
daunomycin and some corresponding congeners. 
Their work was prompted by the observation that the 
apparently flexible sugar-chromophore system, 
characterized by the bond rotations $r and & defined 
in flg.2, adopts similar conformations in the crystals 
mentioned above. This preferred crystal conformation 
has been suggested to be the active biological confor- 
mation as well as a minimum energy conformation 
[4,11]. Neidel and Taylor have specifically calculated 
the conformational energy associated with rotations $r 
and $2 using molecular mechanics [ 121. The particular 
set of potential functions, e g., atomic charge densities, 
used in these calculations are not given. The remainder 
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Fig.1. Chemical structure and ring-numbering of: (a) doxo- 
rubicin; (b) daunomycin. 
of the molecule, that is all other bond rotations, bond 
lengths and angles, has been frozen into the crystal 
conformation of the daunomycin-pyridlne structure. 
Only one lowconformational region in (@r, &)-space 
is found in these studies. The minimum energy con- 
formation in this region is close to those observed 
crystal structures. This is taken as evidence in support 
of the crystal conformation being the active con- 
formation which fits a general DNA-binding model 
[4,13-151. 
Constraining all bond rotation angles, other than 
$r and $2, to the crystal structure values might sig- 
nificantly bias the results of the conformational 
analysis in favor of the crystal conformation. In 
particular, deletion of the 9-hydroxyl group gave 
rise to a second minimum energy conformation 
different from that corresponding to the crystal 
structure [lo]. This new stable conformer state might 
also be realized with the 9hydroxyl present by 
rotating this group about its C-O bond. Hence, we 
decided to perform a generalized conformational 
analysis. Doxorubicin was selected because of its 
biological importance, and it has not been considered 
in previous conformational analyses. However, as we 
show the intramolecular conformational preferences 
of daunomycin and doxorubicin are virtually identical. 
259 
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Fig.2. Arbitrary atom and torsional rotation angle numbering for doxorubicin. 
2. Methods 
The N-bromoacetyldaunomycin crystal structure 
was used as the skeletal structure to determine the 
initial valence geometry of doxorubicin. The oxygen 
atom (O-39 in fig.2) and hydrogen atoms were 
located according to standard bond lengths and angles. 
The final valence geometry was determined using a 
consistent force field arrived at by variable metric 
energy minimization [ 161. The crystal structure 
coordinates plus hydrogen and O-39 oxygen positions 
provided the starting point in the energy minimiza- 
tion. The residual charge densities used in this calcula- 
tion were determined using the CNDQ/2 method. In 
arriving at suitable CNDO/2 charges for doxorubicin, 
it was necessary to partition the molecule into smaller 
fragments whose charges were independently obtained 
and pieced together in order to yield a single consis- 
tent charge distribution for doxorubicin as a whole. 
The charge distributions for the neutral (NHZ) and 
charged (N-s) forms of doxorubicin are given in 
fig.3. 
The valence geometry was held fured in all subse- 
260 
quent conformational analyses. In addition to bond 
rotations@r and &,bond rotations us-&, as defined 
in fig.2, were also considered as limited degrees of 
conformational freedom. Both scanning and mini- 
mizing conformational energy as a function of the $+ 
was carried out using the CAMSEQ-II system [ 171 
and its family of molecular mechanics potential 
functions [ 12,181. Consistent force-field energy mini- 
mizations [ 161 were repeated using the minimum 
energy conformations found in the fmed valence 
geometry scan calculations as starting points. The 
relative zero values for the ~ii, i > 2, are chosen as 
cis/fruns planar conformer states. $i - & E 0” is the 
same as that in [lo]. 
3. Results 
The first conformational scan was performed by 
simultaneously varying both @r and & from O-360” 
at 10” intervals, with all other degrees of conforma- 
tional freedom futed, for the neutral molecule. The 
free-space and aqueous-solvent conformational energy 
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Fig.3. Atomic charge distribution on neutral (NH, 9) and charged (N*H,) doxorubicin. 
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Fig.4. Conformational energy maps for @, and & of neutral doxorubicin: (a) free-space map; (b) aqueous-solvent map. Energy 
contours are in kcal/mol. 
maps are shown in fig.4. The effect of the aqueous 
medium on relative conformer stability is quite small. 
Consequently solvent contributions were neglected in 
subsequent neutral molecule studies. Aqueous solvent- 
dependent conformational studies could not be per- 
formed for the charged form of doxorubicin because 
the appropriate N’Hs solvation parameters are not 
available. 
The @r 4 90”) & = 280’ minimum energy 
conformer corresponds to the crystal structure. How- 
ever, two other energy minima are observed, one of 
which is the global energy minimum for the two- 
dimensional scan. This conformer is located at 
@r = 250”, & = 260” and is -3.0 kcal/mol more 
stable than the ‘crystal’ conformer. The global 
minimum structure is stabilized by a hydrogen bond 
between (022-H46) and the sugar ring oxygen, 03 1. 
The distance between 022 and 03 1 is only -2.62 a. 
However, the distance between H46 and 03 1 is 
-1.95 A which is longer than 0 . . . H distances of 
hydrogen bonds involving hydroxyl groups. In 
essence, the stability of this conformation, relative to 
the crystal conformer, depends upon the ability to 
form the (022-H46) . . .031 hydrogen bond. 
The third conformer, which corresponds to the 
sugar ring being nearly parallel to the anthraquinone 
ring is located at Br = 60”, e2 = 160”. This structure 
is >9.5 kcal/mol less stable than the global energy 
minimum conformation. Therefore it was neglected 
in subsequent calculations. 
Multidimensional, fxed valence geometry energy 
minimization calculations were next carried out for 
$1 to &a. The starting values for glycosidic bond 
rotations #r and $a were either (90”) 280’) or (2.50’) 
260’), while $s--$s were individually assigned 
rotameric states which would be theoretically 
expected. The set of hypothetical starting conformer 
values were generated using the ROTAMER option of 
CAMSEQ-II. The torsional rotations r#+& were 
always assigned initial values consistent with the 
N-bromoacetal derivative crystal conformation. 
The global energy minimum conformer state is 
shown in figSa and is close to the global minimum 
realized from fig.4. The secondary minimum (cor- 
responding to the crystal structure) is shown in fig.5b. 
The minimum energy conformations are described in 
table 1 along with the crystal conformations of 
daunomycin, carminomycin and N-bromoacetyl- 
daunomycin. 
The minimum energy conformers found for the 
neutral form of doxorubicin were used as respective 
starting point in energy minimizations of the charged 
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w (b) 
Fii.5. Stereo-stick models of: (a) the global minimum energy 
conformation; (b) the ‘crystal’ conformation. 
FIg.6. Dependence of the position of the H52 atom upon the 
conformational energy of the global minimum conformer 
of doxorubicin. 
form (N+H,) of doxorubicin, and the neutral and in table 1. It can be seen that the neutral and charged 
charged form of daunomycin. The corresponding forms of both doxorubicin and daunomycin are all 
minimum energy conformer states are also presented quite similar to one another. 
ENERGY 
(Kcollmolr) 
160 360 
+ (Ii-12---23-52) 
Table 1 
Conformational features of some observed daunomycln derivatives and calculated oxorubicin 
and daunomycin minimum energy conformers 
Compound 4% $2 Hydrogen bondinga Mb (kcal/mol) 
Daunomycin 
-pyridine xtal 
Carminomycin 
xtal 
Wbromoacethyl- 
daunomycin xtal 
Doxorubicin-NH, 
Conformer I 
Conformer II 
Doxorubicln-N’H, 
Conformer I 
Conformer II 
Daunomycin-NH, 
Conformer I 
Conformer II 
Daunomycin-N’H, 
Conformer I 
Conformer II 
125” 
117” 
102” 
259” 
77O 
259O 257” d(031 -H46) = 2.27 A 0 
77O 288O 1.5 
258” 257’ d(031-H46) = 2.24 A 0 
79” 289’ 5.0 
258” 257” c&031-H46) = 2.26 A 0 
79” 288’ 1.8 
292” 
290” 
281” 
257” 
288” 
d(029-H52) = 2.12 A - 
d(029-H 023) = 2.80 A - 
d(031-H 023) = 2.89 A 
- 
d(031-H46) = 1.95 A 
d(039-H52) = 2.22 A 
0 
4.6 
a Using atom numbering fg2 
b Global minimum energy conformer I has its energy set equal to zero 
263 
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4, Discussion 
The major finding from thii work is a stable con- 
formation in both doxorubicin and daunomycin dif- 
ferent from the crystal conformation. This new con- 
formation is characterized by a stablizing bifurcated 
hydrogen bond involving the S-oxygen and 6.hydroxyl 
group of the anthraquinone ring and the S-oxygen of 
the sugar ing. Space fiuing molecular model building 
indicates that doxorubicin can inter&ate between 
adjacent bases of double helical DNA, in this new con- 
formation, such that the protonated sugar amino 
nitrogen atom can be close to a phosphate group of 
the polynucleotide backbone. Thii has been suggested 
as an important component to the DNA binding 
mechanism [4,13-151. 
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